| Penny Marie Holley, FNP | |
|
3964 Goodman Rd E Ste 128-129, Southaven, MS 38672-8761 | |
| (662) 655-0456 | |
| (662) 655-0457 |
| Full Name | Penny Marie Holley |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 3964 Goodman Rd E Ste 128-129, Southaven, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013524495 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 868493 (Mississippi) | Primary |
| Entity Name | Newsom Healthcare Of Desoto County Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205243649 PECOS PAC ID: 1759609340 Enrollment ID: O20150410001254 |
News Archive
Psoriasis is an inflammatory skin condition that affects some 125 million people worldwide. It is characterized by itchy, scaly skin plaques. The exact cause of psoriasis is unclear.
The Seattle Times examines how the Bill & Melinda Gates Foundation's goal to eradicate malaria is shaping aspects of global research.
Alcohol consumption is a definite risk factor for several cancers, irrespective of whether intake is light, moderate or heavy, according to a statement released by the American Society of Clinical Oncology (ASCO).
Researchers presented data today on ARQ 092, an AKT inhibitor in Phase 1 clinical development by ArQule, Inc. at the AACR Annual Meeting held in Washington, D.C., April 6-10, showing that this novel, oral agent inhibits the AKT pathway and has a manageable safety profile in an ongoing Phase 1 clinical trial.
The heredity substance DNA is the blueprint of our life. Like an instruction manual it contains all the information needed for cells and the body to function properly.
› Verified 3 days ago
| Entity Name | Mays Medical Wellness Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649790437 PECOS PAC ID: 6406113299 Enrollment ID: O20171204001138 |
News Archive
Psoriasis is an inflammatory skin condition that affects some 125 million people worldwide. It is characterized by itchy, scaly skin plaques. The exact cause of psoriasis is unclear.
The Seattle Times examines how the Bill & Melinda Gates Foundation's goal to eradicate malaria is shaping aspects of global research.
Alcohol consumption is a definite risk factor for several cancers, irrespective of whether intake is light, moderate or heavy, according to a statement released by the American Society of Clinical Oncology (ASCO).
Researchers presented data today on ARQ 092, an AKT inhibitor in Phase 1 clinical development by ArQule, Inc. at the AACR Annual Meeting held in Washington, D.C., April 6-10, showing that this novel, oral agent inhibits the AKT pathway and has a manageable safety profile in an ongoing Phase 1 clinical trial.
The heredity substance DNA is the blueprint of our life. Like an instruction manual it contains all the information needed for cells and the body to function properly.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Penny Marie Holley, FNP 3964 Goodman Rd E Ste 128-129, Southaven, MS 38672-8761 Ph: (662) 655-0456 | Penny Marie Holley, FNP 3964 Goodman Rd E Ste 128-129, Southaven, MS 38672-8761 Ph: (662) 655-0456 |
News Archive
Psoriasis is an inflammatory skin condition that affects some 125 million people worldwide. It is characterized by itchy, scaly skin plaques. The exact cause of psoriasis is unclear.
The Seattle Times examines how the Bill & Melinda Gates Foundation's goal to eradicate malaria is shaping aspects of global research.
Alcohol consumption is a definite risk factor for several cancers, irrespective of whether intake is light, moderate or heavy, according to a statement released by the American Society of Clinical Oncology (ASCO).
Researchers presented data today on ARQ 092, an AKT inhibitor in Phase 1 clinical development by ArQule, Inc. at the AACR Annual Meeting held in Washington, D.C., April 6-10, showing that this novel, oral agent inhibits the AKT pathway and has a manageable safety profile in an ongoing Phase 1 clinical trial.
The heredity substance DNA is the blueprint of our life. Like an instruction manual it contains all the information needed for cells and the body to function properly.
› Verified 3 days ago
Ms. Sherlean D Shugars, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2149 Stateline Rd W, Southaven, MS 38671 Phone: 662-342-1112 | |
Mrs. Christy Le Anne Egbert, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 122 Airways Pl, Southaven, MS 38671 Phone: 662-349-9990 Fax: 662-349-2620 | |
Misty Burton, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 391 Southcrest Cir, Southaven, MS 38671 Phone: 662-349-2659 | |
Rebecca Holly T Robertson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 122 Airways Pl, Southaven, MS 38671 Phone: 662-349-9990 Fax: 662-349-2620 | |
Debra Gail Gill, RNC, MSN, WHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4892 Briarton Dr, Southaven, MS 38672 Phone: 901-262-0332 | |
Jessica N Brown, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 55 Physicians Ln, Southaven, MS 38671 Phone: 662-655-2136 |